Alzheimer Disease/Dementia

 
Adjuvanted Vaccine Against RSV Associated with Substantial Reduced Risk of Dementia
June 30, 2025

The adjuvanted RSV vaccine, in particular, was associated with a 29% reduction in the risk of dementia in the subsequent 18 months, a University of Oxford study found.

Only Half of Patients Adherent to Antidementia Medication Regimens at 1 Year: New Meta-Analysis Results
June 26, 2025

Suboptimal adherence with antidementia drugs is associated with poorer clinical outcomes including accelerated disease progression and symptomatology.

5 Challenges Physicians Face When Screening for Cognitive Decline
June 19, 2025

Primary care clinicians are generally the first clinical contact for older adults with early signs of dementia. Our survey uncovered 5 primary challenges to being in that role.

Physician Survey Results: Primary Care Knowledge of Screening for Cognitive Decline
June 17, 2025

New survey finds that most PCPs screen for mild cognitive impairment, but time is an issue, guidelines are few, and low levels of confidence persist.

Late-Life Mood Disorders Show Strong Association with Tau and Amyloid Pathology, Study Reveals
June 13, 2025

Authors say their findings support the accumulating evidence that late-life mood disorders may be a prodromal manifestation of dementia vs a risk factor alone.

Cycling Linked to 19% Lower Risk of Dementia in Large UK Biobank Study
June 12, 2025

Cycling and mixed cycling were associated with a reduced risk of all-cause dementia, including of young onset, as well as increased hippocampal volume.

Older Adults are Open to Cognitive Assessment for Dementia in Primary Care But Obstacles Loom Large, a New Study Finds
June 05, 2025

A study reveals low clinician engagement in digital cognitive assessments for dementia in primary care, highlighting workflow and other barriers to early detection.

FDA Clears First Blood Test for Alzheimer Disease: Daily Dose
June 02, 2025

Your daily dose of the clinical news you may have missed.

Alzheimer's Association, Senate Champions Refute HHS Secretary Kennedy's Misinformation Head On During Tense Budget Hearing
May 28, 2025

Senate hearing reveals tensions between scientific consensus and HHS Secretary Kennedy's claims on Alzheimer research funding and priorities.

Real-World Memory Clinic Data Suggest Lecanemab Use Is Feasible, Practical for Adults with Alzheimer Disease
May 20, 2025

Adults with early AD who were treated with lecanemab in a specialty memory clinic experienced adverse events comparable to those seen in clinical trials.